JMJay L. Milo
Jay L. Milo
*This is an algorithmically generated author record based on publicly available information.
Research Subjects
Jay L. Milo has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Gary L. Norman
INOVA Diagnostics, Inc., 9900 Old Grove Road, San Diego, CA 92131-1638, USA
3 shared publications - Zakera Shums
INOVA Diagnostics, Inc., 9900 Old Grove Road, San Diego, CA 92131-1638, USA
3 shared publications - Chelsea Bentow
Research and Development, Autoimmunity, Werfen, Autoimmunity Headquarters and Technology Center, San Diego, CA 92131-1638, USA
2 shared publications - Ciaran P. Kelly
Celiac Center, Beth Israel Deaconess Medical Center, Harvard Medical School Celiac Research Program, Boston, USA
2 shared publications - Daniel A. Leffler
Celiac Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
2 shared publications - Eduardo Mauriño
Small Intestine Section, Department of Medicine, Hospital de Gastroenterología “Dr. Carlos Bonorino Udaondo”, Buenos Aires, Argentina
2 shared publications
Latest Publications
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Mo1036 - Prevalence of Primary Biliary Cholangitis-Related Autoantibodies in Patients with Celiac Disease
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Mo1036 - Prevalence of Primary Biliary Cholangitis-Related Autoantibodies in Patients with Celiac Disease
- 1 March 2018
- Published by Elsevier in Autoimmunity Reviews
- Vol. 17 (3) , 267-275
Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype
- 1 March 2018
- Published by Elsevier in Autoimmunity Reviews
- Vol. 17 (3) , 267-275
Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S266-S267
The Combination of Serum I-Fabp and Specific Serology are Highly Predictive Non-Invasive Diagnostic Tools for Celiac Disease in High Pre-Test Populations
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S266-S267
The Combination of Serum I-Fabp and Specific Serology are Highly Predictive Non-Invasive Diagnostic Tools for Celiac Disease in High Pre-Test Populations
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S890
Tu1382 Correlation of Celiac Serologies and Intestinal Fatty Acid-Binding Protein with Marsh Score and Quantitative Histology
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S890
Tu1382 Correlation of Celiac Serologies and Intestinal Fatty Acid-Binding Protein with Marsh Score and Quantitative Histology
- 1 February 2015
- Published by Elsevier in Clinica Chimica Acta
- Vol. 441, 176-181
Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA
- 1 February 2015
- Published by Elsevier in Clinica Chimica Acta
- Vol. 441, 176-181
Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA